The Spike of SARS-CoV-2: Uniqueness and Applications

Front Immunol. 2021 Jul 8:12:663912. doi: 10.3389/fimmu.2021.663912. eCollection 2021.

Abstract

The Spike (S) protein of the SARS-CoV-2 virus is critical for its ability to attach and fuse into the host cells, leading to infection, and transmission. In this review, we have initially performed a meta-analysis of keywords associated with the S protein to frame the outline of important research findings and directions related to it. Based on this outline, we have reviewed the structure, uniqueness, and origin of the S protein of SARS-CoV-2. Furthermore, the interactions of the Spike protein with host and its implications in COVID-19 pathogenesis, as well as drug and vaccine development, are discussed. We have also summarized the recent advances in detection methods using S protein-based RT-PCR, ELISA, point-of-care lateral flow immunoassay, and graphene-based field-effect transistor (FET) biosensors. Finally, we have also discussed the emerging Spike mutants and the efficacy of the Spike-based vaccines against those strains. Overall, we have covered most of the recent advances on the SARS-CoV-2 Spike protein and its possible implications in countering this virus.

Keywords: COVID-19; SARS-CoV-2; diagnostics; drugs; mutations; spike protein; vaccines.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • COVID-19 / diagnosis
  • COVID-19 / prevention & control
  • COVID-19 / virology
  • COVID-19 Drug Treatment
  • COVID-19 Testing
  • COVID-19 Vaccines / immunology
  • Host-Pathogen Interactions
  • Humans
  • Mutation
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / isolation & purification
  • SARS-CoV-2 / metabolism*
  • Species Specificity
  • Spike Glycoprotein, Coronavirus / chemistry
  • Spike Glycoprotein, Coronavirus / genetics
  • Spike Glycoprotein, Coronavirus / immunology
  • Spike Glycoprotein, Coronavirus / metabolism*

Substances

  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2